Literature DB >> 16380537

Angiotensin-II type 1 receptor-mediated hypertension in D4 dopamine receptor-deficient mice.

Martin J Bek1, Xiaoyan Wang, Laureano D Asico, John E Jones, Shaopeng Zheng, Xiaoxi Li, Gilbert M Eisner, David K Grandy, Robert M Carey, Patricio Soares-da-Silva, Pedro A Jose.   

Abstract

Dopamine receptors are important in systemic blood pressure regulation. D4 receptors are expressed in the kidney and brain, but their role in cardiovascular regulation is unknown. In pentobarbital-anesthetized mice, systolic and diastolic blood pressures were elevated in sixth-generation D4 receptor-deficient (D4(-/-)) mice and in tenth-generation D4(-/-) mice compared with D4 wild-type (D4(+/+)) littermates. The conscious blood pressures measured via a chronic arterial (femoral) catheter or telemetry (carotid) were also higher in D4(-/-) mice than in D4 littermates. Basal renal and plasma renin concentrations were similar in the 2 mouse strains. The protein expression of angiotensin II type 1 receptor was increased in homogenates of kidney (330+/-53%, n=5) and brain (272+/-69%, n=5) of D4(-/-) mice relative to D4(+/+) mice (kidney: 100+/-12%, n=5; brain: 100+/-32%, n=5). The expression of the receptor in renal membrane was also increased in D4(-/-) mice (289+/-28%, n=8) relative to D4(+/+) mice (100+/-14%, n=10). In contrast, the expression in the heart was similar in the 2 strains. Bolus intravenous injection of angiotensin II type 1 receptor antagonist losartan initially decreased mean arterial pressures to a similar degree in D4(-/-) and D4(+/+) littermates. However, the hypotensive effect of losartan dissipated after 10 minutes in D4(+/+) mice, whereas the effect persisted for >45 minutes in D4(-/-) mice. We conclude that the absence of the D(4) receptor increases blood pressure, possibly via increased angiotensin II type 1 receptor expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16380537     DOI: 10.1161/01.HYP.0000198427.96225.36

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  33 in total

1.  Activation of D4 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells.

Authors:  Ken Chen; Kun Deng; Xiaoyan Wang; Zhen Wang; Shuo Zheng; Hongmei Ren; Duofen He; Yu Han; Laureano D Asico; Pedro A Jose; Chunyu Zeng
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

Review 2.  Between candidate genes and whole genomes: time for alternative approaches in blood pressure genetics.

Authors:  Jacob Basson; Jeannette Simino; D C Rao
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

3.  Activation of the D4 dopamine receptor attenuates proliferation and migration of vascular smooth muscle cells through downregulation of AT1a receptor expression.

Authors:  Changqing Yu; Jianghua Chen; Weiwei Guan; Yu Han; Wei Eric Wang; Xukai Wang; Hongyong Wang; Pedro A Jose; Chunyu Zeng
Journal:  Hypertens Res       Date:  2015-04-02       Impact factor: 3.872

Review 4.  Dopamine receptors: important antihypertensive counterbalance against hypertensive factors.

Authors:  Chunyu Zeng; Pedro A Jose
Journal:  Hypertension       Date:  2010-11-22       Impact factor: 10.190

Review 5.  Astrocytes and the Renin Angiotensin System: Relevance in Disease Pathogenesis.

Authors:  Ann Tenneil O'Connor; Michelle A Clark
Journal:  Neurochem Res       Date:  2018-06-01       Impact factor: 3.996

6.  Serotonin and dopamine in essential hypertension.

Authors:  Charles T Stier
Journal:  Am J Hypertens       Date:  2012-12-28       Impact factor: 2.689

Review 7.  Dopamine and angiotensin as renal counterregulatory systems controlling sodium balance.

Authors:  John J Gildea
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-01       Impact factor: 2.894

8.  Effects of decreased renal cortical expression of G protein-coupled receptor kinase 4 and angiotensin type 1 receptors in rats.

Authors:  Junichi Yatabe; Hironobu Sanada; Sanae Midorikawa; Shigeatsu Hashimoto; Tsuyoshi Watanabe; Peter M Andrews; Ines Armando; Xiaoyan Wang; Robin A Felder; Pedro A Jose
Journal:  Hypertens Res       Date:  2008-07       Impact factor: 3.872

9.  D5 dopamine receptor decreases NADPH oxidase, reactive oxygen species and blood pressure via heme oxygenase-1.

Authors:  Quansheng Lu; Yu Yang; Van Anthony Villar; Laureano Asico; John E Jones; Peiying Yu; Hewang Li; Edward J Weinman; Gilbert M Eisner; Pedro A Jose
Journal:  Hypertens Res       Date:  2013-02-21       Impact factor: 3.872

10.  Chronic regulation of the renal Na(+)/H(+) exchanger NHE3 by dopamine: translational and posttranslational mechanisms.

Authors:  Ming Chang Hu; Francesca Di Sole; Jianning Zhang; Paul McLeroy; Orson W Moe
Journal:  Am J Physiol Renal Physiol       Date:  2013-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.